KZA kazia therapeutics limited

Abstract 2550, Dr Partick Wen - ASCO 2020. Journal of Clinical...

  1. 1,206 Posts.
    lightbulb Created with Sketch. 941
    Abstract 2550, Dr Partick Wen - ASCO 2020. Journal of Clinical Oncology - published online 25 May 2020.

    Escalation portion of phase II study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K/mTOR inhibitor paxalisib (GDC-0084) in glioblastoma (GBM) with unmethylated O6-methylguanine-methyltransferase (MGMT) promotor status.

    https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.2550

    Regards.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.